Clinical trials are essential to the advancement of medicine. New drugs and devices are tested on people as the last step before the drug or device becomes available to those who need it.

Technological progress is enabling vast improvements in pharma, in drug development, and across the new landscape of healthcare. Clinical trials are at the forefront of bringing new treatments to market in a safe and timely manner. To keep up with the times, constant process improvement in clinical trials is therefore essential. New blood microsampling systems using Mitra^® devices, driven by Volumetric Absorptive Microsampling (VAMS™) technology, function as an essential link between the promise of smarter healthcare, the new wave of clinical trials, and the stuff of human life.

Update: This event has now ended. The on-demand replay is now available.

We get a lot of questions about the specifics of succeeding with microsampling technologies in the bioanalytical lab, as well as some larger questions around applications in pharma, in clinical trials, and across the spectrum of clinical trials. This is your chance to have your questions answered, including the ones you didn't even know you had.

This year’s conference of the European Federation for Exploratory Medicines Development (EUFEMED), held May 15 – 17 in Lyon, France, turned a spotlight on “The Changing Landscape of Early Medicines Development.” This included a presentation by Hugues Chanteux on some exciting new work he’s done with his team at UCB Pharma, an innovative pharma company that has done much to move forward the science of blood microsampling.

Some of the biggest challenges in running a clinical trial involve finding and engaging the right participants. Patient recruitment for clinical trials can be complicated. It sometimes leads to research delays or abandonment because of insufficient participation.

The drug development process can be simpler. Recruitment, retention, and adherence / compliance can be improved. Significant points of friction can be removed. Powerful changes can be as simple as the way blood samples are taken.